Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation

Hosted By: Andrea Charles
Rate this Podcast: 
Average: 3 (3 votes)
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Poor solubility is an obvious barrier to advancing potentially efficacious drug candidates. In this interview Jennifer Sheng, Fellow at Novartis, discusses the most efficient approaches for measuring solubility,  why solubility remains a critical challenge in formulation development and how solubility modelling can reduce the R&D timeline. 

Have Your Say
Rate this feature and give us your feedback in the comments section below


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018